Catriona M. McNeil
Royal Prince Alfred Hospital
2 papers in the Anchorcite directory, published between 2014 and 2015, cited 11,682 times in total.
ORCID profileResearch topics
- Cancer Immunotherapy and Biomarkers · 2 papers
- Cutaneous Melanoma Detection and Management · 2 papers
- Melanoma and MAPK Pathways · 2 papers
Frequent co-authors
- Caroline Robert · 2 papers
- Georgina Venetia Long · 2 papers
- Ana Maria Arance · 2 papers
- Laurent Mortier · 2 papers
- Jacob Schachter · 1 paper
- Jean‐Jacques Grob · 1 paper
- ADIL I. DAUD · 1 paper
- Matteo Salvatore Carlino · 1 paper
Papers
- Pembrolizumab versus Ipilimumab in Advanced MelanomaNew England Journal of Medicine · 2015 · 6,034 citations
BACKGROUND: The immune checkpoint inhibitor ipilimumab is the standard-of-care treatment for patients with advanced melanoma. Pembrolizumab inhibits the programmed cell death 1 (PD-1) immune checkpoint and has antitumor activity in patients with advanced melanoma. METHODS: In this randomized, controlled, phase…
- Nivolumab in Previously Untreated Melanoma without BRAF MutationNew England Journal of Medicine · 2014 · 5,648 citations
BACKGROUND: Nivolumab was associated with higher rates of objective response than chemotherapy in a phase 3 study involving patients with ipilimumab-refractory metastatic melanoma. The use of nivolumab in previously untreated patients with advanced melanoma has not been tested in a…
Metadata from OpenAlex (CC0).